A case report of percutaneous intramyocardial septal radiofrequency ablation in an adult with re-obstruction after Morrow procedure.

Published in: European heart journal. Case reports (2024)

Percutaneous intramyocardial septal radiofrequency ablation is feasible and can be one of the options for the treatment of patients with HCM, especially those who cannot choose Morrow procedure. However, it still needs a large sample of clinical trials to validate its clinical effectiveness.

Keyphrases

radiofrequency ablation
hypertrophic cardiomyopathy
clinical trial
minimally invasive
randomized controlled trial
systematic review
left ventricular
heart failure
atrial fibrillation
phase ii
smoking cessation